Publication:
The design of biodegradable ofloxacin-based core-shell microspheres: Influence of the formulation parameters on in vitro characterization

dc.contributor.authorSEZER, ALİ DEMİR
dc.contributor.authorsSezer, Ali Demir; Akbuga, Julide
dc.date.accessioned2022-03-12T18:05:35Z
dc.date.accessioned2026-01-11T19:17:35Z
dc.date.available2022-03-12T18:05:35Z
dc.date.issued2012
dc.description.abstractOfloxacin (OFL), second-generation fluoroquinolone, is a broad-spectrum antibiotic which is active against both Gram-positive and Gram-negative bacteria. However, OFL has a short biological half life (8-9 h) and poor stability in serum and needs frequently repeated doses during the treatment. The objective of this study was to fabricate the fucospheres and chitosan microspheres containing a poorly soluble drug, OFL, and to compare the formulation parameters influencing the in vitro properties of microparticles such as size, zeta potential, encapsulation efficiency and drug release characteristics. Particle size of fucospheres and chitosan microspheres has been found to be 0.61-1.48 mu m and 1.05-2.08 mu m, respectively. The zeta potentials have changed between 5.6 mV and 28.0 mV for fucospheres; 22.3 mV and 42.4 mV for chitosan microspheres. The fucospheres have had higher drug encapsulation efficiency than those of chitosan microspheres. The particle size, surface charge, encapsulation efficiency and in vitro drug release from both fucospheres and chitosan microspheres have been affected by type and concentration of the polymers used. The release mechanism from most of the microsphere formulations has been fitted to Higuchi kinetic model. It can be concluded that OFL-encapsulated fucospheres can be a potential delivery system for antibiotics.</.
dc.identifier.doi10.3109/10837450.2010.529145
dc.identifier.eissn1097-9867
dc.identifier.issn1083-7450
dc.identifier.pubmed20977313
dc.identifier.urihttps://hdl.handle.net/11424/230725
dc.identifier.wosWOS:000298001600014
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofPHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCHITOSAN MICROSPHERES
dc.subjectDRUG-DELIVERY
dc.subjectSUSTAINED-RELEASE
dc.subjectNANOPARTICLES
dc.subjectENCAPSULATION
dc.subjectENROFLOXACIN
dc.subjectFUCOSPHERE
dc.subjectLIPOSOMES
dc.subjectFUCOIDAN
dc.subjectSYSTEM
dc.titleThe design of biodegradable ofloxacin-based core-shell microspheres: Influence of the formulation parameters on in vitro characterization
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage124
oaire.citation.issue1
oaire.citation.startPage118
oaire.citation.titlePHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
oaire.citation.volume17

Files